18 and older, male only, with Substance Abuse or Domestic Violence. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Participant Fathers Self-reporting Engagement in Risky Sexual BehaviorsPrimary· At Baseline, at 6 months follow up
The number of participants that responded 'yes' to any of the following questions on the PhenX Toolkit Sexual Risk Behavior will be reported as self-reporting engagement in risky sexual behaviors; a) engaging in unprotected sexual encounters, b) more than one partner, c) anal sex with man in the last 6 months.
Baseline
Group
Value
95% CI
HoMBRES Intervention Group - Father
42
Diabetes Prevention Intervention Group - Father
38
6 months follow up
Group
Value
95% CI
HoMBRES Intervention Group - Father
38
Diabetes Prevention Intervention Group - Father
53
The Number of Participant Fathers Self-reporting Experiences of Intra-partner ViolencePrimary· At Baseline, at 6 months
As measured using the PhenX Toolkit Exposures to Violence self-reported instrument. The variable was recoded using four categories: (1) "Your partner physically hurt you; (2) Insult or talk down to you; (3) Threaten you with harm; (4) Scream or curse at you. The responses are scored on a Likert-type scale 1=Never, 2=Rarely, 3=Sometimes, 4=Frequently, and 5=Always. The number of participants reporting 3 or higher on the Likert scale to any of the four categories, will be recorded as experiencing intra-partner violence.
Baseline
Group
Value
95% CI
HoMBRES Intervention Group - Father
10
Diabetes Prevention Intervention Group - Father
9
6 months follow up
Group
Value
95% CI
HoMBRES Intervention Group - Father
10
Diabetes Prevention Intervention Group - Father
5
The Number of Days Participant Fathers Reported Drinking in the Past 90 Days.Primary· At Baseline, at 6 months
The number of days participant reported drinking in the past 90 days using the Time-Line Followback self-reported questionnaire.
Baseline
Group
Value
95% CI
HoMBRES Intervention Group - Father
8.59
± 15.26
Diabetes Prevention Intervention Group - Father
6.72
± 11.98
6 months follow up
Group
Value
95% CI
HoMBRES Intervention Group - Father
11.08
± 20.20
Diabetes Prevention Intervention Group - Father
8.48
± 14.37
HIV Knowledge as Measured by the Brief HIV Knowledge QuestionnairePrimary· At Baseline, at 6 months
As measured by the Brief HIV Knowledge Questionnaire. The proportion of correct answers will be reported (ranging from 0 to 1), with a score closer to 1 indicating higher HIV knowledge.
Baseline
Group
Value
95% CI
HoMBRES Intervention Group - Father
0.65
± 0.18
Diabetes Prevention Intervention Group - Father
0.65
± 0.21
6-months follow up
Group
Value
95% CI
HoMBRES Intervention Group - Father
0.81
± 0.19
Diabetes Prevention Intervention Group - Father
0.69
± 0.19
HIV Self-Efficacy as Measured by Self-Efficacy for STI and HIV ScalePrimary· At Baseline, at 6 months
Self-Efficacy for Sexually Transmitted Infection (STI) and HIV Scale is a 9-item scale measuring the level of confidence in the ability to prevent STI and HIV infection. The measure uses a 5-point Likert scale (1=not sure at all to 5= completely sure). Total score ranges 9 to 45, with a higher score indicating a higher level of HIV self-efficacy.
Baseline
Group
Value
95% CI
HoMBRES Intervention Group - Father
38.30
± 5.10
Diabetes Prevention Intervention Group - Father
38.80
± 6.10
6 months follow up
Group
Value
95% CI
HoMBRES Intervention Group - Father
40.20
± 3.70
Diabetes Prevention Intervention Group - Father
38.50
± 5.40
The Number of Drinks Per Day Over the Past 90 Days.Primary· At Baseline, at 6 months
The number of drinks per day over the past 90 days using the Timeline Followback.
Baseline
Group
Value
95% CI
HoMBRES Intervention Group - Father
2.82
± 3.15
Diabetes Prevention Intervention Group - Father
2.35
± 2.43
6 months follow up
Group
Value
95% CI
HoMBRES Intervention Group - Father
2.89
± 3.23
Diabetes Prevention Intervention Group - Father
3.06
± 3.98
Level of Self-reported Communication With Son as Measured by the Parental Practicing ScaleSecondary· At Baseline, At 6 months
The self-reported Parenting Practices Scale has a total score ranging from 1-5, with higher scores indicating higher levels of parental monitoring among the fathers. The adolescents responded to the son's version of the scale.
Baseline
Group
Value
95% CI
HoMBRES Intervention Group - Father
4.1
± 0.8
Diabetes Prevention Intervention Group - Father
4.3
± 0.6
HoMBRES Intervention Group - Adolescent
3.41
± 0.92
HoMBRES Diabetes Control Group - Adolescent
3.36
± 0.96
6 months follow up
Group
Value
95% CI
HoMBRES Intervention Group - Father
4.2
± 0.6
Diabetes Prevention Intervention Group - Father
4.4
± 0.6
HoMBRES Intervention Group - Adolescent
3.27
± 1.09
HoMBRES Diabetes Control Group - Adolescent
3.47
± 1.07
Sponsor's own description
The overall objective of this project is to adapt and enhance HoMBReS (Hispanic Men Building Respect, Education, and Safety within Families /Hombres Manteniendo Respeto, Educacion y Seguridad de Familia), a Center for Disease Control (CDC)-identified best-evidence HIV behavioral intervention designed to reduce substance abuse, family violence, and HIV/AIDS (SAVA) among sexually active heterosexual Latino seasonal farmworkers (LSFWs) in rural areas.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT06627764 — SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families
· NA
· recruiting
NCT06899308 — Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees
· recruiting
NCT06880705 — The Trans-Led Care Study
· NA
· recruiting
NCT06852170 — Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prev
· NA
· recruiting
NCT05776316 — Harm Reduction Services
· NA
· recruiting
Other University of Miami trials
Trials by the same sponsor.
NCT06003712 — Exploring the Effect of Mindfulness on Quality of Life (QoL) in Spinal Cord Injury (SCI)
· NA
· not yet recruiting
NCT06077071 — MRIdian "RADAR" Trial
· NA
· not yet recruiting
NCT07472413 — Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project
· Phase 3
· not yet recruiting
NCT07322289 — Antibiotic-coated Braided Suture Study
· NA
· not yet recruiting
NCT07469592 — eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Miami
Last refreshed: 17 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03730987.